June 2, 2014 / 12:52 PM / 4 years ago

Activist Pershing Square starts process to change Allergan board

June 2 (Reuters) - Activist investor Pershing Square on Monday said it launched a process to call a special meeting of Allergan Inc shareholders, a move that could turn over most of the drug company’s board and open the door to a takeover by Valeant Pharmaceuticals Inc.

Pershing CEO Bill Ackman, whose hedge fund owns 9.7 percent of Allergan, urged the company to negotiate with Valeant and said a merger deal could be done within a week. (Reporting by Rod Nickel in Winnipeg, Manitoba, Editing by Franklin Paul)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below